loadpatents
name:-0.1622850894928
name:-0.063902854919434
name:-0.0064599514007568
Zeldis; Jerome B. Patent Filings

Zeldis; Jerome B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zeldis; Jerome B..The latest application filed is for "methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of intermediate lymphocytic lymphom".

Company Profile
5.70.147
  • Zeldis; Jerome B. - Princeton NJ
  • Zeldis; Jerome B. - Princetone NJ
  • Zeldis; Jerome B - Princeton NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
Grant RE48,890 - Zeldis January 11, 2
2022-01-11
Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
Grant 11,116,782 - Zeldis September 14, 2
2021-09-14
Methods Using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione For Treatment Of Intermediate Lymphocytic Lymphom
App 20200276175 - Zeldis; Jerome B.
2020-09-03
Methods Using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione For Treatment Of Intermediate Lymphocytic Lymphom
App 20190374529 - Zeldis; Jerome B.
2019-12-12
Methods Of Treating Myelodysplastic Syndromes With A Combination Therapy Using Lenalidomide And Azacitidine
App 20190269712 - Zeldis; Jerome B.
2019-09-05
Methods And Compositions Using Immunomodulatory Compounds For Treatment And Management Of Cancers And Other Diseases
App 20190175575 - Zeldis; Jerome B.
2019-06-13
Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
Grant 10,206,914 - Zeldis Feb
2019-02-19
Methods Using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione For Treatment Of Mantle Cell Lymphomas
App 20180263968 - Zeldis; Jerome B.
2018-09-20
Methods Of Treating Myelodysplastic Syndromes With A Combination Therapy Using Lenalidomide And Azacitidine
App 20180207185 - Zeldis; Jerome B.
2018-07-26
Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers
Grant 10,001,483 - Yarchoan , et al. June 19, 2
2018-06-19
Methods of treating myelodysplastic syndromes using lenalidomide
Grant 9,925,207 - Zeldis March 27, 2
2018-03-27
Methods for treating newly diagnosed multiple myeloma with 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with second active agents
Grant 9,662,321 - Zeldis May 30, 2
2017-05-30
Methods For Treating Multiple Myeloma With 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione After Stem Cell Transplantation
App 20170112819 - Zeldis; Jerome B.
2017-04-27
Methods Using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione For Treatment Of Certain Leukemias
App 20170095464 - Zeldis; Jerome B.
2017-04-06
Methods Using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione For Treatment Of Mantle Cell Lymphomas
App 20170027923 - Zeldis; Jerome B.
2017-02-02
Methods For The Treatment Of Kaposi's Sarcoma Or Kshv-induced Lymphoma Using Immunomodulatory Compounds, And Uses Of Biomarkers
App 20160377621 - YARCHOAN; Robert ;   et al.
2016-12-29
Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
Grant 9,498,472 - Zeldis November 22, 2
2016-11-22
Compositions And Methods For The Treatment Of Viral Diseases With Pde4 Modulators
App 20160289188 - Zeldis; Jerome B. ;   et al.
2016-10-06
Methods For Treating Newly Diagnosed Multiple Myeloma With 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione In Combination With Second Active Agents
App 20160263095 - Zeldis; Jerome B.
2016-09-15
Methods for treating respiratory viral infection
Grant 9,408,831 - Zeldis August 9, 2
2016-08-09
Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with a second active agent
Grant 9,393,238 - Zeldis July 19, 2
2016-07-19
Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with antibodies
Grant 9,283,215 - Zeldis March 15, 2
2016-03-15
Methods For Treating Gliomas With 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
App 20160008345 - Zeldis; Jerome B.
2016-01-14
Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a second active agent
Grant 9,155,730 - Zeldis October 13, 2
2015-10-13
Methods Using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione For Treatment Of Certain Leukemias
App 20150265591 - Zeldis; Jerome B.
2015-09-24
Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
Grant 9,101,621 - Zeldis August 11, 2
2015-08-11
Methods for treating newly diagnosed multiple myeloma 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone
Grant 9,101,622 - Zeldis August 11, 2
2015-08-11
Methods For Treating Multiple Myeloma With 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl) Piperidine-2,6-dione In Combination With Second Active Agents
App 20150190386 - Zeldis; Jerome B.
2015-07-09
Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
Grant 9,056,103 - Zeldis June 16, 2
2015-06-16
Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
Grant 9,056,120 - Zeldis June 16, 2
2015-06-16
Methods for treating amyloidosis with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
Grant 9,050,324 - Zeldis June 9, 2
2015-06-09
Methods For Treating Gliomas With 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
App 20150094336 - Zeldis; Jerome B.
2015-04-02
Methods For Treating Non-hodgkin's Lymphoma With 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione In Combination With A Second Active Agent
App 20150094335 - Zeldis; Jerome B.
2015-04-02
Treating Myelodysplastic Syndromes Using Lenalidomide
App 20150038444 - Zeldis; Jerome B.
2015-02-05
Methods For Treating Newly Diagnosed Multiple Myeloma With 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione In Combination With Dexamethasone
App 20140377293 - Zeldis; Jerome B.
2014-12-25
Methods For Treating Multiple Myeloma With 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione After Stem Cell Transplantation
App 20140308344 - Zeldis; Jerome B.
2014-10-16
Methods Using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione For Treatment Of Mantle Cell Lymphomas
App 20140271638 - Zeldis; Jerome B.
2014-09-18
Methods For Treating Non-hodgkin's Lymphoma With 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione In Combination With A Second Active Agent
App 20140206724 - Zeldis; Jerome B.
2014-07-24
Methods For Treating Amyloidosis With 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
App 20140206723 - Zeldis; Jerome B.
2014-07-24
Methods For Treating Multiple Myeloma Using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione In Combination With Antibodies
App 20140186404 - Zeldis; Jerome B.
2014-07-03
Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with proteasome inhibitor
Grant 8,759,375 - Zeldis June 24, 2
2014-06-24
Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas
Grant 8,741,929 - Zeldis June 3, 2
2014-06-03
Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
Grant 8,735,428 - Zeldis May 27, 2
2014-05-27
Methods for treating amyloidosis using 4-(amino)-2-(2,6-Dioxo(3-piperidyl))- isoindoline-1,3-dione
Grant 8,722,647 - Zeldis May 13, 2
2014-05-13
Methods for treating diffuse large B-cell lymphoma with 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with second active agents
Grant 8,722,705 - Zeldis May 13, 2
2014-05-13
Methods Using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione For Treatment Of Certain Leukemias
App 20140112920 - Zeldis; Jerome B.
2014-04-24
Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
Grant 8,673,939 - Zeldis March 18, 2
2014-03-18
Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor
Grant 8,648,095 - Zeldis February 11, 2
2014-02-11
Methods using immunomodulatory compounds for treatment of certain leukemias
Grant 8,632,787 - Zeldis January 21, 2
2014-01-21
Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of acute myelogenous leukemia
Grant 8,623,384 - Zeldis January 7, 2
2014-01-07
Methods For The Treatment Of Sarcoidosis
App 20140004182 - Zeldis; Jerome B.
2014-01-02
Methods for the treatment of myeloproliferative diseases using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
Grant 8,618,136 - Zeldis December 31, 2
2013-12-31
Methods For Treating Diffuse Large B-cell Lymphoma With 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione In Combination With Second Active Agents
App 20130302323 - Zeldis; Jerome B.
2013-11-14
Methods Using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione For Treatment Of Acute Myelogenous Leukemia
App 20130251709 - Zeldis; Jerome B.
2013-09-26
Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione
Grant 8,530,498 - Zeldis September 10, 2
2013-09-10
Methods For Treating Multiple Myeloma With 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione
App 20130231314 - Zeldis; Jerome B.
2013-09-05
Methods Of Treating Myelodysplastic Syndromes With A Combination Therapy Using Lenalidomide And Azacitidine
App 20130202590 - Zeldis; Jerome B.
2013-08-08
Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
Grant 8,492,406 - Zeldis July 23, 2
2013-07-23
Methods For Treating Multiple Myeloma Using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione In Combination With Proteasome Inhibitor
App 20130183381 - ZELDIS; JEROME B.
2013-07-18
Methods For Treating Multiple Myeloma With 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
App 20130177642 - Zeldis; Jerome B.
2013-07-11
Methods For Treating Multiple Myeloma With 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
App 20130177644 - Zeldis; Jerome B.
2013-07-11
Methods For Treating Respiratory Viral Infection
App 20130136770 - Zeldis; Jerome B.
2013-05-30
Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
Grant 8,440,194 - Zeldis May 14, 2
2013-05-14
Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
Grant 8,410,136 - Zeldis April 2, 2
2013-04-02
Methods of treating myelodysplastic syndromes using lenalidomide
Grant 8,404,717 - Zeldis March 26, 2
2013-03-26
Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
Grant 8,404,716 - Zeldis March 26, 2
2013-03-26
Methods For Treatment Of Cognitive And Menopausal Disorders With D-threo Methylphenidate
App 20130053414 - Zeldis; Jerome B. ;   et al.
2013-02-28
Methods For Treating Multiple Myeloma Using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione In Combination With Proteasome Inhibitor
App 20120244214 - Zeldis; Jerome B.
2012-09-27
Methods For Treating Amyloidosis Using 4-(amino)-2-(2,6-dioxo(3-piperidyl))- Isoindoline-1,3-dione
App 20120237595 - Zeldis; Jerome B.
2012-09-20
Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-ox- o-2,3-dihydro-1 h-isoindol-4-yl}-amide
Grant 8,263,637 - Zeldis September 11, 2
2012-09-11
Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione follow by autologous stem cell transplantation
Grant 8,207,200 - Zeldis June 26, 2
2012-06-26
Methods Of Using And Compositions Comprising Pde4 Modulators For Treatment, Prevention And Management Of Tuberculosis
App 20120149716 - Zeldis; Jerome B.
2012-06-14
Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
Grant 8,198,262 - Zeldis June 12, 2
2012-06-12
Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor
Grant 8,198,306 - Zeldis June 12, 2
2012-06-12
Methods Using Immunomodulatory Compounds For Treatment of Certain Leukemias
App 20120135042 - Zeldis; Jerome B.
2012-05-31
Method for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with antibodies
Grant 8,188,118 - Zeldis May 29, 2
2012-05-29
Methods Of Treating Multiple Myeloma Using Melphalan, Prednisone And Lenalidomide
App 20120035145 - Zeldis; Jerome B.
2012-02-09
Methods For Treating Cancers Using Polymorphic Forms Of 3-(4-amino-1-oxo-1,3 Dihydro-isoindol-2-yl)-piperidine-2,6-dione
App 20110275672 - Zeldis; Jerome B. ;   et al.
2011-11-10
Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate
App 20110257227 - ZELDIS; Jerome B. ;   et al.
2011-10-20
Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
Grant 8,034,831 - Zeldis October 11, 2
2011-10-11
Methods Of Treating Myelodysplastic Syndromes Using Lenalidomide
App 20110172273 - Zeldis; Jerome B.
2011-07-14
Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
Grant 7,968,569 - Zeldis June 28, 2
2011-06-28
Methods For Treating Cutaneous Lupus Using Aminoisoindoline Compounds
App 20110104144 - Zeldis; Jerome B. ;   et al.
2011-05-05
Methods For Treating Lymphomas In Certain Patient Populations And Screening Patients For Said Therapy
App 20110064735 - Pietronigro; Dennis ;   et al.
2011-03-17
Methods for treating lymphomas in certain patient populations and screening patients for said therapy
Grant 7,893,045 - Pietronigro , et al. February 22, 2
2011-02-22
Method For Treatment Of Macular Degeneration Using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoi- Soindoline-1,3-dione
App 20110038832 - ZELDIS; Jerome B.
2011-02-17
Methods of using 4-(amino)-2-(2,6-dioxo(3-piperidly))-isoindoline-3-dione for the treatment of myelodysplastic syndromes
Grant 7,863,297 - Zeldis January 4, 2
2011-01-04
Method for the treatment of myelodysplastic syndromes using cyclopropanecarboxylic acid {2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-OXO-2,3-dihy- dro-1 H-isoindol-4-yl}-amide
Grant 7,842,691 - Zeldis November 30, 2
2010-11-30
Methods Of Treating Myelodysplastic Syndromes With A Combination Therapy Using Lenalidomide And Azacitidine
App 20100278779 - Zeldis; Jerome B.
2010-11-04
Methods For Treatment Of Hepatocellular Carcinoma Using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
App 20100260719 - Zeldis; Jerome B.
2010-10-14
Methods for the treatment and management of macular degeneration using cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)eth- yl]-3-oxoisoindoline-4-yl}carboxamide
Grant 7,776,907 - Zeldis August 17, 2
2010-08-17
Methods For Treatment Of Follicular Lymphoma Using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
App 20100196369 - Zeldis; Jerome B.
2010-08-05
Methods And Compositions Using Pde4 Inhibitors For The Treatment And Management Of Cancers
App 20100129363 - Zeldis; Jerome B. ;   et al.
2010-05-27
Methods and Compositions Using Immunomodulatory Compounds for The Treatment and Management of Cancers and Other Diseases
App 20100099711 - ZELDIS; Jerome B.
2010-04-22
Methods For Treatment Of Multiple Myeloma Using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione In Combination With A Proteasome Inhibitor
App 20100093683 - Zeldis; Jerome B.
2010-04-15
Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate
App 20100093797 - Zeldis; Jerome B. ;   et al.
2010-04-15
Methods Using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione For Treatment Of Mantle Cell Lymphomas
App 20100068206 - Zeldis; Jerome B.
2010-03-18
Methods For Treatment Of Colorectal Cancer Using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
App 20100063094 - Zeldis; Jerome B.
2010-03-11
Methods for treatment, modification and management of radiculopathy using 1-oxo-2-(2,6-dioxopiperidin-3yl)-4-aminoisoindoline
Grant 7,612,096 - Zeldis , et al. November 3, 2
2009-11-03
Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
Grant 7,563,810 - Zeldis July 21, 2
2009-07-21
Method of using and comopositions comprising immunomodulatory compounds for the treatment and management of myeloproliferative diseases
App 20090163548 - Zeldis; Jerome B.
2009-06-25
Method For Treating Multiple Myeloma Using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione In Combination With Antibodies
App 20090155265 - Zeldis; Jerome B.
2009-06-18
Methods For The Treatment Of Bladder Cancer Using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
App 20090123416 - Zeldis; Jerome B.
2009-05-14
Chronic, Bolus Adminstration Of D-Threo Methylphenidate
App 20090088455 - Dariani; Maghsoud M. ;   et al.
2009-04-02
Methods For The Treatment Of Scleroderma Using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline
App 20090087407 - Zeldis; Jerome B. ;   et al.
2009-04-02
Methods For The Treatment And Management Of Myeloproliferative Diseases Using 4-(amino)-2-(2,6-dioxo(3-piperidyl)-isoindoline-1,3-dione In Combination With Other Therapies
App 20090088410 - Zeldis; Jerome B.
2009-04-02
Methods for treating lymphomas in certain patient populations and screening patients for said therapy
App 20090081203 - Pietronigro; Dennis ;   et al.
2009-03-26
Method for the Treatment of Myeloproliferative Diseases Using(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2- Methylsulfonylethyl]-4- Acetylaminoisoindoline-1,3- Dione
App 20090010886 - Zeldis; Jerome B.
2009-01-08
Methods for treatment prostate cancer using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
App 20090010877 - Zeldis; Jerome B.
2009-01-08
Methods for treating head or neck cancer using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
App 20080317709 - Zeldis; Jerome B.
2008-12-25
Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3dione
App 20080317708 - Zeldis; Jerome B.
2008-12-25
Methods for treatment of cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
Grant 7,468,363 - Zeldis December 23, 2
2008-12-23
Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione following autologous stem cell transplantation
App 20080292583 - Zeldis; Jerome B.
2008-11-27
Methods for treating sarcoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6 dioxo(3-piperidyl))-isoindoline-1,3-dione
App 20080286232 - Zeldis; Jerome B.
2008-11-20
Methods and Compositions Using Selective Cytokine Inhibitory Drugs for Treatment and Management of Cancers and Other Diseases
App 20080267905 - Zeldis; Jerome B.
2008-10-30
Compositions and methods for the treatment of cancer
Grant 7,435,726 - Zeldis , et al. October 14, 2
2008-10-14
Methods and compositions using immunomodulatory compounds for the treatment and management of central nervous system disorders or diseases
App 20080227816 - Zeldis; Jerome B. ;   et al.
2008-09-18
Methods for treatment of behcet's disease using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
App 20080219948 - Zeldis; Jerome B.
2008-09-11
Methods for treating brain cancer using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6 dioxo(3-piperidyl))-isoindoline-1,3-dione
App 20080219949 - Zeldis; Jerome B.
2008-09-11
Methods for treatment and management of macular degeneration using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
App 20080213219 - Zeldis; Jerome B.
2008-09-04
Method For the Treatment of Myelodysplastic Syndromes Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoi- soindoline-1,3-Dione
App 20080213213 - Zeldis; Jerome B.
2008-09-04
Method for treatment and management of thyroid cancer using immunomodulatory compounds
App 20080206193 - Zeldis; Jerome B.
2008-08-28
Method for the Treatment of Myelodysplastic Syndromes Using 1-Oxo-2-(2,6-Dioxopiperidin-3-Yl-)-4-Methylisoindoline
App 20080199422 - Zeldis; Jerome B.
2008-08-21
Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes
App 20080161360 - Zeldis; Jerome B.
2008-07-03
Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
Grant 7,393,862 - Zeldis July 1, 2
2008-07-01
Methods of using N-{[2-(2,6-dioxo(3-piperidyl)-1,3-dioxoisoindolin-4-yl]methyl}cyclopropyl- -carboxamide for the treatment and management of myelodysplastic syndromes
Grant 7,393,863 - Zeldis July 1, 2
2008-07-01
Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
App 20080145368 - Zeldis; Jerome B.
2008-06-19
Bechet's disease using cyclopropyl-N-carboxamide
App 20080138295 - Zeldis; Jerome B.
2008-06-12
Methods for Treating Cancers Using Polymorphic Forms of 3-(4-Amino-1-Oxo-1,3 Dihydro-Isoindol-2-Yl)-Piperidine-2,6-Dione
App 20080132541 - Zeldis; Jerome B. ;   et al.
2008-06-05
Methods for the treatment of atherosclerosis, using substituted phenethylsulfones
App 20080096952 - Zeldis; Jerome B.
2008-04-24
Methods for treatment of chronic uveitis using cyclopropyl-n-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)eth- yl]-3-oxoisoindoline-4-yl}carboxamide
Grant 7,354,948 - Zeldis April 8, 2
2008-04-08
Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas
App 20080038263 - Zeldis; Jerome B.
2008-02-14
Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline
Grant 7,325,355 - Zeldis February 5, 2
2008-02-05
Methods of Using and Compositions Comprising Immunomodulatory Compounds for Treatment and Management of Macular Degeneration
App 20080027113 - Zeldis; Jerome B.
2008-01-31
Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline
Grant 7,323,479 - Zeldis January 29, 2
2008-01-29
Methods for treatment of ovarian, colorectal or pancreatic cancer using 4-(aminno)-2(2,6-dioxo(3-piperidyl)-isoindoline-1,3-dione
App 20070299020 - Zeldis; Jerome B.
2007-12-27
Methods of Using and Compositions Comprising a Jnk Inhibitor for the Treatment and Management of Asbestos-Related Diseases and Disorders
App 20070270448 - Zeldis; Jerome B.
2007-11-22
Methods for Treatment, Modification and Management of Pain Using 1-Oxo-2-(2,6-Dioxopiperidin-3-yl)-4-Methylisoindoline
App 20070244078 - Zeldis; Jerome B. ;   et al.
2007-10-18
Methods of Using and Compositions Comprising Selective Cytokine Inhibitory Drugs for Treatment and Management of Macular Degeneration
App 20070207121 - Zeldis; Jerome B.
2007-09-06
Methods And Compositions Using Thalidomide For The Treatment And Management Of Cancers And Other Diseases
App 20070208057 - Zeldis; Jerome B.
2007-09-06
Methods of using N-{[2-(2,6-dioxo(3-piperidyl)-1,3-dioxoisoindolin-4-yl]methyl}cyclopropyl- -carboxamide for the treatment and management of myelodysplastic syndromes
App 20070196330 - Zeldis; Jerome B.
2007-08-23
Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system
App 20070190070 - Zeldis; Jerome B. ;   et al.
2007-08-16
Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
App 20070161696 - Zeldis; Jerome B. ;   et al.
2007-07-12
Methods for treating cutaneous lupus using aminoisoindoline compounds
App 20070155791 - Zeldis; Jerome B. ;   et al.
2007-07-05
Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes
Grant 7,189,740 - Zeldis March 13, 2
2007-03-13
Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders
Grant 7,182,953 - Zeldis February 27, 2
2007-02-27
Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis
Grant 7,148,252 - Zeldis December 12, 2
2006-12-12
Methods and compositions using 4-[(cyclopropanecarbonylamino)methyl]-2-(2,6-dioxopiperidin-3-yl)isoindol- e-1,3-dione for the treatment or prevention of cutaneous lupus
App 20060270707 - Zeldis; Jerome B. ;   et al.
2006-11-30
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
Grant 7,115,631 - Zeldis , et al. October 3, 2
2006-10-03
Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline
App 20060199843 - Zeldis; Jerome B.
2006-09-07
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
App 20060183774 - Zeldis; Jerome B. ;   et al.
2006-08-17
Methods for treatment and management of lung cancer using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
App 20060172970 - Zeldis; Jerome B.
2006-08-03
Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
App 20060166932 - Zeldis; Jerome B.
2006-07-27
Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases
App 20060165649 - Zeldis; Jerome B.
2006-07-27
Methods of using and compositions comprising PDE4 modulators for treatment, prevention and management airway inflammation
App 20060148882 - Zeldis; Jerome B. ;   et al.
2006-07-06
Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury
App 20060122228 - Zeldis; Jerome B. ;   et al.
2006-06-08
Methods and compositions using JNK inhibitors for treatment and management of central nervous system injury
App 20060122179 - Zeldis; Jerome B. ;   et al.
2006-06-08
Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
App 20060105993 - Zeldis; Jerome B.
2006-05-18
Methods and compositions using PDE4 modulators for treatment and management of central nervous system injury
App 20060106085 - Zeldis; Jerome B. ;   et al.
2006-05-18
Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
App 20060069065 - Zeldis; Jerome B.
2006-03-30
Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
App 20060030594 - Zeldis; Jerome B.
2006-02-09
Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders
App 20060004054 - Zeldis; Jerome B.
2006-01-05
Methods for preserving tissue
App 20050266391 - Bennett, Brydon L. ;   et al.
2005-12-01
Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of pulmonary hypertension
App 20050239842 - Zeldis, Jerome B.
2005-10-27
Methods of using and compositions comprising thalidomide for the treatment and management of pulmonary hypertension
App 20050239719 - Zeldis, Jerome B.
2005-10-27
Methods of using and compositions comprising PDE4 modulators for the treatment and management of pulmonary hypertension
App 20050239867 - Zeldis, Jerome B.
2005-10-27
Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
App 20050234017 - Zeldis, Jerome B.
2005-10-20
Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
App 20050222209 - Zeldis, Jerome B. ;   et al.
2005-10-06
Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders
App 20050214328 - Zeldis, Jerome B. ;   et al.
2005-09-29
Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
App 20050203142 - Zeldis, Jerome B. ;   et al.
2005-09-15
Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseases
App 20050182097 - Zeldis, Jerome B. ;   et al.
2005-08-18
Methods for treatment of cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoind- ol-2-YL)-piperidine-2,6-dione
App 20050176681 - Zeldis, Jerome B.
2005-08-11
Compositions and methods for the treatment of cancer
App 20050148524 - Zeldis, Jerome B. ;   et al.
2005-07-07
Methods of using and compositions comprising PDE4 modulators for the treatment and management of asbestos-related diseases and disorders
App 20050142104 - Zeldis, Jerome B.
2005-06-30
Methods and compositions using immunomodulatory compounds for the treatment and management of central nervous system disorders or diseases
App 20050143344 - Zeldis, Jerome B. ;   et al.
2005-06-30
Methods of using and compositions comprising thalidomide for treatment, modification and management of fibromyalgia
App 20050119194 - Zeldis, Jerome B. ;   et al.
2005-06-02
Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders
App 20050100529 - Zeldis, Jerome B.
2005-05-12
Chronic, bolus administration of D-threo methylphenidate
App 20050049279 - Dariani, Maghsoud M. ;   et al.
2005-03-03
Drug-coated stents and methods of use therefor
App 20050019366 - Zeldis, Jerome B.
2005-01-27
Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes
App 20040220144 - Zeldis, Jerome B.
2004-11-04
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
App 20040204456 - Zeldis, Jerome B. ;   et al.
2004-10-14
Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment and management of macular degeneration
App 20040091454 - Zeldis, Jerome B.
2004-05-13
Methods of using and compositions comprising immunomodulatory compounds for treatment and management of macular degeneration
App 20040091455 - Zeldis, Jerome B.
2004-05-13
Methods for the treatment, prevention and management of macular degeneration
App 20040092568 - Zeldis, Jerome B.
2004-05-13
Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
App 20040087558 - Zeldis, Jerome B. ;   et al.
2004-05-06
Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myeloproliferative diseases
App 20040087546 - Zeldis, Jerome B.
2004-05-06
Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
App 20040087642 - Zeldis, Jerome B. ;   et al.
2004-05-06
Methods for using JNK inhibitors for treating or preventing disease-related wasting
App 20040034084 - Zeldis, Jerome B.
2004-02-19
Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
App 20040029832 - Zeldis, Jerome B.
2004-02-12
Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes
App 20040028660 - Hariri, Robert J. ;   et al.
2004-02-12
Chronic, bolus administration of D-threo methylphenidate
App 20030232857 - Dariani, Maghsoud M. ;   et al.
2003-12-18
Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis
App 20030149025 - Zeldis, Jerome B.
2003-08-07
Chronic, bolus administration of D-threo methylphenidate
Grant 6,602,887 - Dariani , et al. August 5, 2
2003-08-05
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
App 20020198234 - Zeldis, Jerome B. ;   et al.
2002-12-26
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
Grant 6,486,177 - Zeldis , et al. November 26, 2
2002-11-26
Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders
App 20020054899 - Zeldis, Jerome B.
2002-05-09
Compositions and methods for the treatment of cancer
App 20020035090 - Zeldis, Jerome B. ;   et al.
2002-03-21
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
App 20020022640 - Zeldis, Jerome B. ;   et al.
2002-02-21
Chronic, bolus administration of D-threo methylphenidate
App 20010041717 - Dariani, Maghsoud M. ;   et al.
2001-11-15
Chronic, bolus administration of D-threo methylphenidate
Grant 6,255,325 - Dariani , et al. July 3, 2
2001-07-03
Company Registrations
SEC0001433982ZELDIS JEROME B

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed